← Back to headlines
BioLineRx Reports Mixed Q4 Earnings with EPS Beat, Revenue Miss
BioLineRx announced its latest financial results, reporting GAAP EPS of $0.00, which beat estimates by $0.68, but revenue of $1.18M, which missed estimates by $0.3M.
23 Mar, 11:02 — 23 Mar, 11:02
Sources
Showing 1 of 1 sources



